Orthofix saw first quarter 2025 sales grow, according to financial results posted May 6.
Five things to know about Q1:
1. Orthofix’s sales, including its recently discontinued M6-C and M6-L disc, were $193.6 million. Excluding M6 sales, Orthofix’s quarterly revenue grew 3.9% with $189.2 million.
2. Global spine sales of $159 million represent a 3% increase year over year.
3. Global orthopedic sales increased 9.1% year over year with $29.8 million.
4. Orthofix operated with a net loss of $53.1 million. That net loss grew year over year compared to a $36 million net loss in the same time last year.
5. Orthofix projects its full year revenue to reach $808 million to $816 million, excluding M6 sales.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
